2010年，上市许可申请数据下降的药品包含新药和仿制药，仿制药在完成申请方面下降特别明显。
For 2010, the decline in MA applications encompasses both new products and generics and is particularly marked in finalized applications.
2010年，上市许可申请数据下降的药品包含新药和仿制药，仿制药在完成申请方面下降特别明显。
For 2010, the decline in MA applications encompasses both new products and generics and is particularly marked in finalized applications.
应用推荐